|
Delayed
Sao Paulo
15:50:38 2026-08-25 EDT
|
5-day change | 1st Jan Change | ||
| 63.72 BRL | +1.43% |
|
+2.51% | +11.15% |
| 08-25 | Wall Street Wants Receipts |  |
| 08-25 | Lakefront Biotherapeutics, Gilead Secure Another Orphan Drug Designation for Skin Disorder Drug in US | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,100B | |||||
| 658B | - | - | - | ||
| 470B | |||||
| 372B | |||||
| 304B |
Select your edition
All financial news and data tailored to specific country editions
